U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07004296) titled 'A Phase 1 Study of HDM2005 in Patients With Advanced Solid Tumor' on May 27.
Brief Summary: This is a study evaluating the efficacy, safety, and pharmacokinetics ofHDM2005 in participants with metastatic solid tumors.
Study Start Date: May 29
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumors
Intervention:
DRUG: HDM2005
HDM2005 will be administered via IV infusion.
Recruitment Status: RECRUITING
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....